STOCK TITAN

Nucor (NUE) director Christopher Kearney receives 755-share equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

KEARNEY CHRISTOPHER J reported acquisition or exercise transactions in this Form 4 filing.

NUCOR CORP director Christopher J. Kearney received an equity award of 755 shares of common stock as compensation. The Form 4 classifies this as a grant or award, not an open‑market purchase, with a stated price of $0.00 per share. Following the award, Kearney directly holds 46,753 common shares. According to the footnote, the grant takes the form of restricted stock units that vest immediately, while the actual shares will be issued as soon as administratively practicable after he leaves the board.

Positive

  • None.

Negative

  • None.
Insider KEARNEY CHRISTOPHER J
Role null
Type Security Shares Price Value
Grant/Award Common Stock 755 $0.00 --
Holdings After Transaction: Common Stock — 46,753 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Equity award size 755 shares Common stock grant to director on 2026-06-01
Award price per share $0.00 per share Director stock grant classified as compensation
Shares owned after grant 46,753 shares Total direct Nucor common stock holdings post-transaction
Transaction code A (grant, award, or other acquisition) Non-derivative acquisition reported on Form 4
Transaction direction Acquire Form 4 transaction_direction field
restricted stock units financial
"The restricted stock units vest immediately upon grant."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
grant, award, or other acquisition regulatory
"transaction_code_description: Grant, award, or other acquisition"
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
common stock financial
"The shares of common stock reported are issuable to the reporting person"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KEARNEY CHRISTOPHER J

(Last)(First)(Middle)
1915 REXFORD ROAD

(Street)
CHARLOTTE NORTH CAROLINA 28211

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NUCOR CORP [ NUE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/01/2026A755(1)A$046,753D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The shares of common stock reported are issuable to the reporting person or, if applicable, to his or her estate, as soon as administratively practicable after the termination of the reporting person's service on the board of directors. The restricted stock units vest immediately upon grant.
/s/ Kelly J. Wilmoth, attorney-in-fact for Mr. Kearney06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did NUCOR CORP (NUE) director Christopher J. Kearney report on this Form 4?

Christopher J. Kearney reported receiving an award of 755 shares of NUCOR common stock. The filing shows this as a grant or award rather than an open‑market purchase, increasing his directly held position to 46,753 shares after the transaction.

Was the NUCOR CORP (NUE) Form 4 transaction a stock purchase or a compensation grant?

The Form 4 describes the transaction as a grant or award acquisition, not a market purchase. Kearney received 755 shares of common stock at a price of $0.00 per share, consistent with equity-based director compensation rather than buying shares in the open market.

How many NUCOR CORP (NUE) shares does Christopher J. Kearney hold after this Form 4?

After the reported grant, Kearney directly holds 46,753 NUCOR common shares. The new award of 755 shares, delivered as restricted stock units, is included in this post‑transaction total disclosed in the Form 4’s ownership column.

How are the restricted stock units in this NUCOR CORP (NUE) Form 4 structured?

The filing states the restricted stock units vest immediately upon grant. However, the underlying common shares are issuable to Kearney, or his estate if applicable, as soon as administratively practicable after his service on the board of directors ends.

Does the NUCOR CORP (NUE) Form 4 indicate any derivative securities or option exercises?

The Form 4 data show no derivative transactions or option exercises associated with this event. The derivative summary is empty, and the only reported activity is a non‑derivative acquisition of 755 common shares through an equity award.